Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy

Chronic kidney disease is highly prevalent, affecting 10% to 15% of the adult population worldwide and is associated with increased cardiovascular morbidity and mortality. As chronic kidney disease worsens, a unique cardiovascular phenotype develops characterized by heart muscle disease, increased a...

Descripción completa

Detalles Bibliográficos
Autores principales: Law, Jonathan P., Price, Anna M., Pickup, Luke, Radhakrishnan, Ashwin, Weston, Chris, Jones, Alan M., McGettrick, Helen M., Chua, Winnie, Steeds, Richard P., Fabritz, Larissa, Kirchhof, Paulus, Pavlovic, Davor, Townend, Jonathan N., Ferro, Charles J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Contemporary Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428638/
https://www.ncbi.nlm.nih.gov/pubmed/32212912
http://dx.doi.org/10.1161/JAHA.120.016041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428638/
https://www.ncbi.nlm.nih.gov/pubmed/32212912
http://dx.doi.org/10.1161/JAHA.120.016041

Ejemplares similares